| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
cytochrome P450 family 1 subfamily A member 2 | 0.494 | 0.923 | 2.5E-10 |
|
group | 0.100 | None | 0.930 | 43 | 3 | 1992 | 2020 | ||||||||
|
cytochrome P450 family 3 subfamily A member 4 | 0.462 | 0.885 | 5.8E-11 |
|
group | 0.100 | None | 1.000 | 11 | 0 | 2017 | 2020 | ||||||||
|
adenosine A2a receptor | 0.526 | 0.769 | 0.60 |
|
group | 0.100 | None | 1.000 | 11 | 4 | 2008 | 2019 | ||||||||
|
cytochrome P450 family 2 subfamily C member 9 | 0.506 | 0.885 | 1.3E-10 |
|
group | 0.090 | None | 1.000 | 9 | 0 | 2017 | 2020 | ||||||||
|
lysine acetyltransferase 2B | 0.563 | 0.692 | 0.99 |
|
group | 0.080 | None | 1.000 | 8 | 0 | 2017 | 2020 | ||||||||
|
chromatin assembly factor 1 subunit A | 0.581 | 0.808 | 1.00 |
|
group | 0.080 | None | 1.000 | 8 | 0 | 2017 | 2020 | ||||||||
|
cytochrome P450 family 2 subfamily C member 19 | 0.467 | 0.846 | 6.5E-20 |
|
group | 0.080 | None | 0.875 | 8 | 0 | 2002 | 2018 | ||||||||
|
cytochrome P450 family 2 subfamily D member 6 | 0.437 | 0.885 | 1.1E-25 |
|
group | 0.070 | None | 1.000 | 7 | 0 | 2003 | 2020 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta | 0.319 | 0.885 | 1.00 |
|
group | 0.060 | None | 1.000 | 6 | 0 | 2017 | 2019 | ||||||||
|
ATM serine/threonine kinase | 0.374 | 0.885 | 5.6E-47 |
|
group | 0.060 | None | 1.000 | 6 | 0 | 2008 | 2019 | ||||||||
|
interleukin 6 | 0.248 | 0.962 | 0.32 |
|
group | 0.060 | None | 0.667 | 6 | 0 | 2002 | 2019 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta | 0.322 | 0.885 | 1.00 |
|
group | 0.050 | None | 1.000 | 5 | 0 | 2017 | 2019 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma | 0.320 | 0.885 | 1.4E-06 |
|
group | 0.050 | None | 1.000 | 5 | 0 | 2017 | 2019 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha | 0.292 | 0.923 | 1.00 |
|
group | 0.050 | None | 1.000 | 5 | 0 | 2017 | 2019 | ||||||||
|
insulin like growth factor 1 | 0.318 | 0.885 | 0.27 |
|
group | 0.050 | None | 1.000 | 5 | 0 | 2018 | 2019 | ||||||||
|
cytochrome P450 family 2 subfamily B member 6 | 0.428 | 0.846 | 1.9E-10 |
|
group | 0.050 | None | 1.000 | 5 | 0 | 2017 | 2019 | ||||||||
|
tumor necrosis factor | 0.231 | 0.962 | 0.80 |
|
group | 0.050 | None | 1.000 | 5 | 0 | 2017 | 2019 | ||||||||
|
caspase 3 | 0.351 | 0.923 | 0.10 |
|
group | 0.050 | None | 1.000 | 5 | 0 | 2017 | 2019 | ||||||||
|
adenosine A1 receptor | 0.578 | 0.692 | 1.5E-02 |
|
group | 0.040 | None | 1.000 | 4 | 1 | 2017 | 2019 | ||||||||
|
acetylcholinesterase (Cartwright blood group) | 0.445 | 0.885 | 1.00 |
|
group | 0.040 | None | 1.000 | 4 | 0 | 2017 | 2018 | ||||||||
|
mechanistic target of rapamycin kinase | 0.343 | 0.885 | 1.00 |
|
group | 0.040 | None | 1.000 | 4 | 0 | 2017 | 2019 | ||||||||
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
group | 0.040 | None | 1.000 | 4 | 2 | 1997 | 2018 | ||||||||
|
ryanodine receptor 1 | 0.489 | 0.808 | 1.6E-29 |
|
group | 0.040 | None | 1.000 | 4 | 15 | 2018 | 2019 | ||||||||
|
N-acetyltransferase 2 | 0.451 | 0.885 | 3.3E-06 |
|
group | 0.040 | None | 1.000 | 4 | 0 | 1992 | 2019 | ||||||||
|
synuclein alpha | 0.427 | 0.885 | 0.88 |
|
group | 0.040 | None | 0.500 | 4 | 1 | 2015 | 2019 |